Top Tweets for #OVERALLPOPULATION

Herbert Loong, MBBS, FASCO

11 months ago

📢 Our report of #Asian subgroup data of #LIBRETTO431: #selpercatinib vs. #ChemoIO #firstline treatment in #RET_FusionPositive #NSCLC 🫁 has been published in @IASLC #JTOCRR. 54% of this global trial were from #EastAsia 🌏. Results consistent with #overallpopulation and further echos the importance of early identification through molecular profiling in #Asia. Full paper can be found here: https://t.co/OysP8GNBCu @EliLillyandCo @CUHKMedicine @apoddc @APCLC_2023 #drugdevelopment

herbloong's tweet photo. 📢 Our report of #Asian subgroup data of #LIBRETTO431: #selpercatinib vs. #ChemoIO #firstline treatment in #RET_FusionPositive #NSCLC 🫁 has been published in @IASLC #JTOCRR. 54% of this global trial were from #EastAsia 🌏.

Results consistent with #overallpopulation and further echos the importance of early identification through molecular profiling in #Asia.

Full paper can be found here: https://t.co/OysP8GNBCu

@EliLillyandCo @CUHKMedicine @apoddc @APCLC_2023 #drugdevelopment

herbloong's tweet photo. 📢 Our report of #Asian subgroup data of #LIBRETTO431: #selpercatinib vs. #ChemoIO #firstline treatment in #RET_FusionPositive #NSCLC 🫁 has been published in @IASLC #JTOCRR. 54% of this global trial were from #EastAsia 🌏.

Results consistent with #overallpopulation and further echos the importance of early identification through molecular profiling in #Asia.

Full paper can be found here: https://t.co/OysP8GNBCu

@EliLillyandCo @CUHKMedicine @apoddc @APCLC_2023 #drugdevelopment

herbloong's tweet photo. 📢 Our report of #Asian subgroup data of #LIBRETTO431: #selpercatinib vs. #ChemoIO #firstline treatment in #RET_FusionPositive #NSCLC 🫁 has been published in @IASLC #JTOCRR. 54% of this global trial were from #EastAsia 🌏.

Results consistent with #overallpopulation and further echos the importance of early identification through molecular profiling in #Asia.

Full paper can be found here: https://t.co/OysP8GNBCu

@EliLillyandCo @CUHKMedicine @apoddc @APCLC_2023 #drugdevelopment

herbloong's tweet photo. 📢 Our report of #Asian subgroup data of #LIBRETTO431: #selpercatinib vs. #ChemoIO #firstline treatment in #RET_FusionPositive #NSCLC 🫁 has been published in @IASLC #JTOCRR. 54% of this global trial were from #EastAsia 🌏.

Results consistent with #overallpopulation and further echos the importance of early identification through molecular profiling in #Asia.

Full paper can be found here: https://t.co/OysP8GNBCu

@EliLillyandCo @CUHKMedicine @apoddc @APCLC_2023 #drugdevelopment

2

25

3

2

2K

Wendy @roo2ujbrand2001

almost 7 years ago

@realDonaldTrump AMAZING! That the numbers in an EXTREMELY #Unreliable #PartisanPoll went up a percentage point since yesterday. #DoTheFuckingMath you #Moron! .53×.25(at best)= 0.13= 13% of the #OVERALLPOPULATION! #Dipshit

0

1

0

0

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users